These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 4017475

  • 21. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J, Heidrich H, Lammersen T.
    J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Restless legs and crampi in the night. Double blind study with Circonyl in patients with defective peripheric arterial circulation (author's transl)].
    Hürlimann F.
    Schweiz Rundsch Med Prax; 1974 Feb 19; 63(7):194-5. PubMed ID: 4605921
    [No Abstract] [Full Text] [Related]

  • 24. [Effects of xanthinol nicotinate on the irrigation of the musculature of the limbs and of the skin].
    Klüken N, Schmidt H.
    Angiologia; 1972 Feb 19; 24(6):271-80. PubMed ID: 4641643
    [No Abstract] [Full Text] [Related]

  • 25. [Current role of sympathetic nerve surgery in most peripheral chronic obliterative arteriopathies of the lower limbs].
    Gaspari A, Lania M, Valerii B, Ipri D.
    Ann Ital Chir; 1984 Feb 19; 56(2):143-57. PubMed ID: 6508040
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V.
    Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Muscular clearance of xenon (Xe-133) as a measure of the effectiveness of Provasan and Bametan for the correction of blood flow in the lower limbs].
    Jonderko G, Szramek-Urbaniak A, Lewandowski J.
    Pol Tyg Lek; 1981 Jan 19; 36(3):103-6. PubMed ID: 6113581
    [No Abstract] [Full Text] [Related]

  • 29. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S, Manganaro A, Barbera MC, Cento D, Buda D, Arrigo F, Consolo F.
    Minerva Cardioangiol; 1986 Nov 19; 34(11):745-9. PubMed ID: 2949163
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment of hyperdyslipidemia in chronic atherosclerotic peripheral obliterating arteriopathies of the lower limbs].
    Bagliani A, Argenteri A, La Rosa A.
    Clin Ter; 1982 Dec 31; 103(6):647-61. PubMed ID: 7160147
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Conservative treatment of arterial occlusion with streptokinase administered intra-arterially].
    Korzekwa P, Poplicha T.
    Wiad Lek; 1992 Feb 31; 45(3-4):84-6. PubMed ID: 1413801
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effect of O-betahydroxyethyl-rutosides (HR) on the number of platelet-leukocyte aggregates in patients with occlusive arterial disease.
    Bielawiec M, Kiersnowska-Rogowska B, Dabrowski S, Lukjan H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Feb 31; 106(1):103-8. PubMed ID: 88383
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Volumetric rate of blood flow in obliterative diseases of the arteries of the extremities].
    Stepanov NI.
    Vestn Khir Im I I Grek; 1974 Feb 31; 112(2):67-73. PubMed ID: 4458215
    [No Abstract] [Full Text] [Related]

  • 40. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
    Fényes G, Gótzy G, Fehrentheil L.
    Ther Hung; 1975 Feb 31; 23(2):64-66. PubMed ID: 1188705
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.